Peptide API subsidiary of Aurobindo Pharma with a plant near Hyderabad. Makes generic peptide APIs and runs GMP contract projects from mg to kg scale.
- Model
- CDMO
- Manufacturer?
- Yes
Plecanatide is a guanylate cyclase-C agonist for chronic idiopathic constipation (Trulance).
5 listed companies hold an active US Type II Drug Master File for Plecanatide API, based in India (2), China (2), Taiwan (1). 4 have a regulator record of GMP manufacturing.
Ordered by score. Scores follow the published rules and are not affected by paid placement. Updated 2026-11-13.
Source: FDA Drug Master File list. Holding a DMF is a regulatory filing, not an FDA approval.
Peptide API subsidiary of Aurobindo Pharma with a plant near Hyderabad. Makes generic peptide APIs and runs GMP contract projects from mg to kg scale.
Taiwanese API maker founded in 1964, trading as Cenra API Solutions, offering CMO/CDMO services. Holds US DMFs for difelikefalin, plecanatide and setmelanotide.
Hyderabad-based MSN Group entity holding US DMFs for 11 peptide APIs, including semaglutide and tirzepatide. MSN runs 27 plants in India, the USA and Indonesia.
Chinese peptide drug manufacturer producing APIs and finished products.
Beijing API company, founded 2006, that holds DMFs and has its APIs made in partner facilities under its own quality control. Holds US DMFs for 13 peptide APIs.
Companies holding active US DMFs for Plecanatide include Auro Peptides Ltd, Chunghwa Chemical Synthesis & Biotech Co., Ltd. (Cenra API Solutions), MSN Life Sciences Private Ltd (MSN Group), Hybio Pharmaceutical and ALP Pharm Beijing Co., Ltd.. Other manufacturers may supply it without a US DMF.
Among listed DMF holders: India (2), China (2), Taiwan (1).
No. FDA reviews a DMF when a drug application references it and does not approve DMFs on their own.